Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Reported Basic Consolidated EPS Of $-1.0223 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) for the period ended 2015-12-31 was $-1.0223. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-1.0223.

EPS from continuing operations

Coming to basic EPS from continuing operations, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) reported $-1.0223 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-1.0223.

EPS contribution from parent

For the annual period ended 2015-12-31, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) received basic EPS of $-1.0223 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-1.0223.

Basic net EPS

For the annual period ended 2015-12-31, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) reported basic net EPS of $-1.02. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-1.02.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-1.0101. For the quarter ended 2015-12-31, consolidated diluted EPS was $-1.0101.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-1.0101 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-1.0101.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-1.03. For the quarterly period ended 2015-12-31, net diluted EPS was $-1.03.

Diluted EPS from parent

From the parent company, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) received diluted EPS of $-1.0101 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-1.0101.

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) posted net basic EPS reading of $-1.02 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-1.02 was for the quarter ended 2015-12-31.

Net diluted EPS for Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) for the annual period ended 2015-12-31 was $-1.03. The company also reported net diluted EPS reading of $-1.03 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 13.276 while for the quarter ended 2015-12-31 is 13.276.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 13.437 while for the quarter ended 2015-12-31 is 13.437.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 19 times, 1 visits today)